[Federal Register Volume 83, Number 242 (Tuesday, December 18, 2018)]
[Notices]
[Pages 64848-64850]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27178]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with grant and/or
contract proposals applications, the
[[Page 64849]]
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Improving the Reach and Quality of Cancer Care in Rural
Populations
Date: January 18, 2019.
Time: 7:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108 Bethesda, MD 20892-9750, 240-276-6343,
[email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel; NCI SPORE II (P50).
Date: January 29-30, 2019.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Wlodek Lopaczynski, M.D., Ph.D., Scientific
Review Officer, Office of the Director, Division of Extramural
Activities, National Cancer Institute, NIH 9609 Medical Center
Drive, Room 7W514, Bethesda, MD 20892-9750 240-276-6340,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-5: NCI Clinical and Translational R21 and Omnibus R03.
Date: February 1, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue Bethesda, MD 20814.
Contact Person: Robert S. Coyne, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W236, Bethesda, MD 20892-9750 240-276-5120, [email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel; Quantitative Imaging Tools and Methods for Cancer Therapy
Response Assessment.
Date: February 1, 2019.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Bethesda, MD 20892-9750, 240-276-5179, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-3: NCI Clinical and Translational R21 and Omnibus R03.
Date: February 7-8, 2019.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Bethesda, MD 20892-9750, 240-276-7286, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-3: SBIR Contract Review.
Date: February 13-14, 2019.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 2W032, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Biological Comparisons in Patient-Derived Models of Cancer.
Date: February 22, 2019.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Robert S. Coyne, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W236, Bethesda, MD 20892-9750, 240-276-5120, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-7: NCI Clinical and Translational R21 and Omnibus R03.
Date: February 28, 2019.
Time: 7:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W640, Bethesda, MD 20892-9750, 240-276-2432, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCORP Research Bases.
Date: March 5, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W032/034, Rockville, MD 20850.
Contact Person: Michael B. Small, Ph.D., Scientific Review
Officer, Program and Review Extramural Staff Training Office,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W412, Bethesda, MD 20892-9750, 240-
276-6384, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Community Oncology Research Program--Community Sites.
Date: March 7-8, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room TE406, Rockville, MD 20850.
Contact Person: Timothy C. Meeker, M.D., Ph.D., Scientific
Review Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W606, Bethesda, MD 20892-9750, 240-276-6464,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-1 for Provocative Questions.
Date: March 7, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Hasan Siddiqui, Ph.D. , Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W240, Bethesda, MD 20892-9750, 240-276-5122,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-6: NCI Clinical and Translational R21 and Omnibus R03.
Date: March 7-8, 2019.
Time: 5:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel SEP-4 for Provocative Questions.
Date: March 14-15, 2019.
Time: 6:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 64850]]
Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343,
[email protected].
Name of Committee: National Cancer Institute, Special Emphasis
Panel SEP-3 for Provocative Questions.
Date: March 21, 2019.
Time: 7:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Hasan Siddiqui, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W240 Bethesda, MD 20892-9750, 240-276-5122, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel TEP-9: Clonogenic High-Throughput Assay for Anti-Cancer Agents
and Radiation Modulators.
Date: March 28, 2019.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W246 Rockville, MD 20850.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W260, Bethesda, MD, 20892-9750 240-276-5460,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 11, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-27178 Filed 12-17-18; 8:45 am]
BILLING CODE 4140-01-P